Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods Study

被引：0
|
作者：
Simon de Lusignan
Andrew McGovern
William Hinton
Martin Whyte
Neil Munro
Emily D. Williams
Afrodita Marcu
John Williams
Filipa Ferreira
Julie Mount
Manasa Tripathy
Emmanouela Konstantara
Benjamin C. T. Field
Michael Feher
机构：
[1] University of Oxford,Nuffield Department of Primary Care Health Sciences
[2] University of Surrey,Department of Clinical and Experimental Medicine
[3] Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC),Royal College of General Practitioners
[4] University of Exeter,The Institute of Clinical and Biological Sciences
[5] University of Surrey,School of Health Sciences
[6] Eli Lilly and Company,Department of Diabetes
[7] King’s College London,Department of Diabetes and Endocrinology, East Surrey Hospital
[8] Surrey and Sussex Healthcare NHS Trust,undefined
来源：
Diabetes Therapy | 2022年 / 13卷
关键词：
Insulin; GLP1 receptor analogues; Barriers; Initiation; Mixed methods; Primary care; Medical record systems, computerized; Diabetes mellitus, type 2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1789 / 1809
页数：20
相关论文
共 50 条
  • [31] Patients' perceptions on the facilitators and barriers using injectable therapies in dyslipidaemia: An empirical qualitative descriptive international study
    Lee, Geraldine A.
    Durante, Angela
    Baker, Edward E.
    Vellone, Ercole
    Caggianelli, Gabriele
    Dellafiore, Federica
    Khan, Mutiba
    Khatib, Rani
    JOURNAL OF ADVANCED NURSING, 2023, 79 (12) : 4687 - 4696
  • [32] The Role of Nurses and the Facilitators and Barriers in Diabetes Care: A Mixed Methods Systematic Literature Review
    Nikitara, Monica
    Constantinou, Costas S.
    Andreou, Eleni
    Diomidous, Marianna
    BEHAVIORAL SCIENCES, 2019, 9 (06)
  • [33] Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China
    McEwan, Phil
    Baker-Knight, James
    Asbjornsdottir, Bjorg
    Yi, Yunni
    Fox, Aimee
    Wyn, Robin
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2023, 24 (02): : 187 - 196
  • [34] Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China
    Phil McEwan
    James Baker-Knight
    Björg Ásbjörnsdóttir
    Yunni Yi
    Aimee Fox
    Robin Wyn
    The European Journal of Health Economics, 2023, 24 : 187 - 196
  • [35] Current therapies and targets for type 2 diabetes mellitus
    Chellappan, Dinesh K.
    Yap, Wei S.
    Ahmad Suhaimi, Nurfatihah A. B. T.
    Gupta, Gaurav
    Dua, Kamal
    PANMINERVA MEDICA, 2018, 60 (03) : 117 - 131
  • [36] New therapies in the management of type 2 diabetes mellitus
    Hardman, T. C.
    Dubrey, S. W.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (04) : 202 - 207
  • [37] Mechanisms of current therapies for diabetes mellitus type 2
    Thule, Peter M.
    ADVANCES IN PHYSIOLOGY EDUCATION, 2012, 36 (04) : 275 - 283
  • [38] Reality of insulin initiation in Type 2 Diabetes Mellitus
    Luk, Andrea
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S39 - S39
  • [39] Determinants of decision-making for the initiation of resuscitation: a mixed-methods systematic review of barriers and facilitators
    Moghbeli, Golshan
    Roshangar, Fariborz
    Soheili, Amin
    Ahmadi, Fazlollah
    Feizollahzadeh, Hossein
    Hassankhani, Hadi
    INTERNATIONAL JOURNAL OF EMERGENCY MEDICINE, 2024, 17 (01)
  • [40] Barriers and facilitators in relation to starting insulin therapy in type 2 diabetes
    Okazaki, K
    Goto, M
    Yamamoto, T
    Tsujii, S
    Ishii, H
    DIABETES, 1999, 48 : A319 - A319
12345